Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-24-071260
Filing Date
2024-06-13
Accepted
2024-06-13 16:08:33
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B3 tm2417051d1_424b3.htm 424B3 87706
2 GRAPHIC tm2417051d1_424b3img01.jpg GRAPHIC 11595
3 GRAPHIC logo.jpg GRAPHIC 13527
4 GRAPHIC logo_small.jpg GRAPHIC 8776
5 GRAPHIC exh993_1.jpg GRAPHIC 243829
6 GRAPHIC exh993_2.jpg GRAPHIC 239633
  Complete submission text file 0001104659-24-071260.txt   801345
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258741 | Film No.: 241041287
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)